Depomed Announces Restructuring
By

By
Depomed, a Newark, California-headquartered specialty pharmaceutical company, has announced a restructuring plan to reduce staff by approximately 40% to approximately 70 employees. The decision follows Depomed’s agreement to sell its…

FDA Issues Draft Guidance for Rare Pediatric Drug Development
By

By
The US Food and Drug Administration (FDA) has released draft guidance, Pediatric Rare Diseases—A Collaborative Approach for Drug Development Using Gaucher Disease as a Model, to facilitate drug development in…

Fortress Biotech Forms Gene-Therapy Subsidiary
By

By
Fortress Biotech, a New York-based biopharmaceutical company acquiring, developing, and commercializing pharmaceutical and biotechnology products, has formed Tamid Bio, a subsidiary dedicated to developing adeno-associated virus (AAV) gene therapies in…

GSK Invests $50 Million in Genomic Research
By

By
GlaxoSmithKline (GSK) plans to invest £40 million ($53 million) in strengthening initiatives in genetic research in the development of new medicines. The investment expands GSK’s previously announced effort to generate…

Lilly Appoints VP, Early-Phase Development and Immuno-Oncology
By

By
Eli Lilly and Company has appointed Kimberly Blackwell, MD, as Lilly Oncology’s vice president of early-phase development and immuno-oncology, effective March 12, 2018. Blackwell is currently professor of medicine and…

CSL Opens Albumin Manufacturing Facility
By

By
CSL Behring, a specialty biotherapeutics company, has opened a new AU $230-million (US $173-million) manufacturing facility at its site in Broadmeadows, Victoria, Australia for producing albumin, a protein derived from…

Plasticell Partners in Stem-Cell Product
By

By
Plasticell, a Stevenage, UK-based developer of stem-cell technologies and cell therapies, has partnered with Anthony Nolan, a research organization for blood cancers, to progress clinical development of Plasticell’s ex vivo…

Amgen, Carmot Partner in Parkinson’s Disease Drug Pact
By

By
Amgen and Carmot Therapeutics, a Berkeley, California-headquartered biotechnology company, have entered into a multi-year drug discovery collaboration and licensing agreement. As part of the agreement, Carmot will apply its proprietary…

Shire, Rani Therapeutics in Hemophilia Pact
By

By
Shire and Rani Therapeutics, a San Jose, California-based company specializing in the oral delivery of large-drug molecules, have agreed to conduct research on the use of Rani’s pill technology for…

Otsuka Partners in Digital Health
By

By
Otsuka Pharmaceutical and Science 37, a Los Angeles, California-headquartered company focused on “site-less” clinical trials, have signed a strategic collaboration to support efforts to further digitize Otsuka’s mobile clinical study…